NRX Pharmaceuticals, Inc. Earnings Per Share (Basic)
NRX Pharmaceuticals, Inc. (NRXP) reported Earnings Per Share (Basic) of -$0.44 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- NRX Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.44.
- NRX Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.04.
- NRX Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.27.
- NRX Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.98.
- NRX Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was -$1.34.
- NRX Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was -$2.36.
- NRX Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was -$3.98.
- NRX Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was -$0.60.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.44 10-Q · filed 2026-08-14 | -$0.51 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | -$0.04 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | -$1.34 10-K · filed 2026-03-23 | |||||||
| 2025-09-30 | -$0.27 10-Q · filed 2025-11-14 | -$1.54 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | -$0.98 10-Q · filed 2026-08-14 | -$1.34 10-Q · filed 2026-08-14 | ||||||
| 2025-03-31 | -$0.34 10-Q · filed 2026-05-15 | |||||||
| 2024-12-31 | -$2.36 10-K · filed 2026-03-23 | |||||||
| 2024-09-30 | -$0.15 10-Q · filed 2025-11-14 | -$1.59 10-Q · filed 2025-11-14 | ||||||
| 2024-06-30 | -$0.75 10-Q · filed 2025-08-18 | -$1.49 10-Q · filed 2025-08-18 | ||||||
| 2024-03-31 | -$0.74 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | -$3.98 10-K · filed 2025-03-14 | -$0.40 10-K · filed 2024-03-29 | ||||||
| 2023-09-30 | -$0.74 10-Q · filed 2024-11-14 | -$0.07 10-Q · filed 2023-11-14 | -$3.48 10-Q · filed 2024-11-14 | -$0.35 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | -$1.21 10-Q · filed 2024-08-14 | -$0.12 10-Q · filed 2023-08-14 | -$2.81 10-Q · filed 2024-08-14 | -$0.28 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$0.34 10-Q · filed 2025-05-15 | -$0.16 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$0.40 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$0.60 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | -$0.14 10-Q · filed 2023-11-14 | -$0.24 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.45 10-Q · filed 2023-11-14 | -$0.94 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2022-06-30 | -$0.11 10-Q · filed 2023-08-14 | -$0.32 10-Q · filed 2023-08-14 | -$0.81 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$1.47 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||||
| 2022-03-31 | -$0.21 10-Q · filed 2023-05-15 | -$0.72 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$1.40 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$6.27 derived: net income ÷ weighted average shares · filed 2023-05-15 | ||||
| 2021-12-31 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$1.23 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$6.41 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$1.98 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$0.72 10-Q · filed 2022-11-14 | -$0.40 10-Q · filed 2021-11-15 | -$6.27 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.45 10-Q · filed 2022-11-14 | -$1.44 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $0.00 10-Q/A · filed 2022-08-12 | -$0.38 10-Q · filed 2021-08-16 | -$0.66 10-Q · filed 2022-08-15 | -$1.07 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | -$0.71 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | -$1.26 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.44 derived: net income ÷ weighted average shares · filed 2022-08-12 | -$1.45 derived: net income ÷ weighted average shares · filed 2022-08-12 | -$1.51 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$0.15 10-Q/A · filed 2022-08-12 | -$0.15 derived: net income ÷ weighted average shares · filed 2022-08-12 | -$0.20 10-Q/A · filed 2022-08-12 | |||||
| 2020-06-30 | $0.00 derived: net income ÷ weighted average shares · filed 2022-08-12 | -$0.04 10-Q/A · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |